Horizons in Haematology: Insights from the EHA President - European Medical Journal

Horizons in Haematology: Insights from the EHA President

Hematology

The EMJ Podcast | Episode 179

Jonathan is joined by António Almeida, President of the European Hematology Association (EHA); and Professor and Director of the Clinical Haematology Service, Hospital da Luz, Lisbon, Portugal, to discuss his highlights since becoming EHA President. The pair cover the three pillars of EHA, the anticipated topics for the 2024 congress, and how Almeida has implemented a brand-new medical school, as well as much more.

Spotify | Apple | Amazon MusicDownload MP3 (41:31 mins)

 

Speaker bio:

After obtaining his medical degree at Cambridge University, UK, in 1993, António Almeida concluded his specialist training in haematology in 2002. Almeida subsequently completed a clinical research fellowship at Imperial College London, UK, and achieved a PhD for work focusing on the molecular characterisation and targeted therapy for inherited glucose phosphate isomerase deficiency. He is now Director of the Clinical Haematology Service at the Hospital da Luz, Lisbon, Portugal, and following the conclusion of the European Hematology Association (EHA) 2023 Congress, Almeida has taken on the role of EHA President.

Almeida is active in clinical research, with a particular interest in myeloproliferative and myelodysplastic syndromes. He has written book chapters, and published extensively.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.